Medical Communications

Showing 15 posts of 6402 posts found.

shutterstock_339308225

Revealing the missing evidence: Randomised real-life studies in basal insulin therapy

July 10, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, diabetes, real world data

Sanofi’s Riccardo Perfetti, Head of Global Diabetes, and Jukka Westerbacka, Medical Director, Global Medical Affairs, discuss how the significance of …
gagan_singh

AstraZeneca appoint new MD for India

July 7, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, India

AstraZeneca announced a new Managing Director for AstraZeneca Pharma India, with Gagan Singh Bedi beginning the role on 3 July. …
top_ten_1

Top Ten most popular articles on Pharmafile.com this week

July 7, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing most read articles, most read news, top ten

It’s Friday, and we’ve brought together our weekly digest of the articles which proved most popular with our readers. Brexit …
celgene_1_02

Celgene plays catch up with $1.4 billion immunotherapy deal

July 7, 2017 Medical Communications, Sales and Marketing BeiGene, Celgene, immunotherapy, pd-1

Those commentating on Celgene’s latest deal seem to be equally divided between two camps: it is too much money, too …
shutterstock_168864905

Top 50 Selling Products in the World by 2022

July 6, 2017 Medical Communications

This article was originally published in Pharmafile Spring 2017.Opdivo and Revlimid to compete for the top spot in 2022, while …
shutterstock_138095450

New data shows pharma has not cut back on controversial payments to physicians

July 6, 2017 Medical Communications, Sales and Marketing Allergan, Biogen, Celgene, Sanofi, Valeant

Despite increasing controversy arising over the years due to the questionable relationship between physicians and pharma and the money which …
merck_entrance

FDA shutters MSD’s Keytruda combination trials in myeloma

July 6, 2017 Medical Communications, Research and Development MSD, immunotherapy, keytruda, pd-1

Following on from the news last month that enrolment for Keytruda being used alongside Celgene’s Imnovid and Revlimid would have …

Merck Foundation created and CEO set in place

July 5, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Merck Foundation, Merck KGaA

Merck KGaA announced that is has created the Merck Foundation and has appointed Rasha Kelej as its CEO. The role …
eu_and_fda

EMA and FDA harmonise over development of Gaucher drugs

July 5, 2017 Medical Communications, Research and Development, Sales and Marketing EMA, FDA, Gaucher disease

The EMA and the FDA have announced that they have developed a joint proposal to promote more efficient means of …
8384110298_da510e0347_c

Google’s DeepMind app deal with NHS brought into question

July 5, 2017 Medical Communications, Research and Development Alphabet, DeepMind, NHS, google

DeepMind’s deal with the NHS to develop an app that is able to detect possible kidney damage involved 1.6 million …
new_wave_logo_cmyk

Gain insight into what your peers are doing

July 5, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Webinar, wave

When they first came along, webinars were the equivalent of an outside broadcast unit, lots of hardware, dedicated studios and …
brexit_flag_0

Ministers move to clarify drug regulation Post-Brexit

July 4, 2017 Manufacturing and Production, Medical Communications EMA, Jeremy Hunt, MHRA, NHS, NICE

Jeremy Hunt, Health Secretary, and Greg Clark, Business Secretary, have made a bold move to suggest that the UK will …

Forging a path forward in neurological disorders

July 3, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing neurological disorders

The development of innovative treatments for neurological disorders such as dementia has stagnated over the past decade despite being an …
The Gateway to Local Adoption Series

Latest content